Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Development
Pharma
AstraZeneca trumpets new Calquence combos in CLL
With the AMPLIFY trial win, the combination of Calquence, venetoclax and Gazyva may become the first triplet regimen in CLL.
Angus Liu
Jul 29, 2024 10:25am
Nucleus RadioPharma unveils manufacturing pact with ARTBIO
May 7, 2024 8:47am
Cell therapy manufacturer Cellares draws $255M investment round
Aug 24, 2023 9:15am
Trial for controversial China-made Alzheimer's drug aborted
May 13, 2022 4:16pm
AZ, FibroGen clash on roxa's US path forward in CKD anemia
May 10, 2022 8:05am
